Prothrombotic changes in users of combined oral contraceptives containing drospirenone and cyproterone acetate

Prothrombotic changes in users of combined oral contraceptives containing drospirenone and cyproterone acetate.

Effects on acne of two oral contraceptives containing desogestrel and cyproterone acetate.

OBJECTIVE To compare the effects of a low-dose oral contraceptive containing desogestrel (Marvelon) and an anti-androgenic preparation containing cyproterone acetate (Diane) in Oriental women suffering from acne. METHODS In an open-label, bi-center, randomized study, 32 women using Marvelon and 34 using Diane were followed for 6 treatment cycles. The measured variables were objective and subj...

Metabolic Profile In Active Female Students Users And Non-Users Combined Oral Contraceptives

Background. There is to our knowledge metabolic changes induced by combined oral contraceptives (COC) use in regularly active females. Objectives. Analyzing blood cortisol and other biochemical variables in active (COC) users and non-users. Methods. A total of 123 active female students (25 COC users and 98 non-users) volunteered to participate in the study.  The COC users declared 2-3 years ...

A Comparative Efficacy of Low-Dose Combined Oral Contraceptives Containing Desogestrel and Drospirenone in Premenstrual Symptoms

Objective. To compare the efficacy of low-dose COC containing desogestrel (DSG) with drospirenone (DRSP) in the changes of premenstrual symptoms. Methods. In an open-label randomized controlled trial, 90 women with premenstrual syndrome who required COC were randomly recruited and allocated equally to receive either 6 cycles of 20 micrograms ethinyl estradiol (EE)/150 micrograms DSG (DSG group)...

Comparative risks of venous thromboembolism among users of oral contraceptives containing drospirenone and levonorgestrel.

Commentary Background Two case-control studies, both with the involvement of the Boston Collaborative Drug Surveillance Program, have recently been published in the British Medical Journal (Jick et al. 1 and Parkin et al. 2) in which increased risks of venous throm-boembolism (VTE) among users of drospirenone (DRSP)-containing oral contraceptives (OCs) compared with lev-onorgestrel (LNG)-contai...